Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Dexmedetomidine for Procedural Sedation in Cesarean Delivery
NCT07651956Phase 4Not yet recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Nov 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in anxiety disorder, sponsored by Icahn School of Medicine at Mount Sinai. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT07651956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07651956.